BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10124782)

  • 1. Perspectives. Managed competition: antitrust-buster?
    Barnett AA
    Faulkner Grays Med Health; 1993 Apr; 47(14):suppl 4 p.. PubMed ID: 10124782
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitrust exemption: are health providers crying wolf?
    Barnett AA
    J Am Health Policy; 1993; 3(3):38-41. PubMed ID: 10125734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitrust law applicable to managed care contracting.
    Weber RD
    Mich Med; 1995 Apr; 94(4):16-7. PubMed ID: 7791633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testimony on managed competition. Expenditure limits and managed competition.
    Davis K
    Caring; 1993 Jun; 12(6):28, 30-1. PubMed ID: 10125989
    [No Abstract]   [Full Text] [Related]  

  • 5. Managed competition, antitrust, and the Clinton health reform plan: too modest a proposal.
    Kopit WG
    Healthspan; 1993 Nov; 10(10):21-4. PubMed ID: 10130836
    [No Abstract]   [Full Text] [Related]  

  • 6. Questions and answers about managed competition.
    Clancy CM; Himmelstein DU; Woolhandler S
    Health PAC Bull; 1993; 23(1):30-2. PubMed ID: 10126177
    [No Abstract]   [Full Text] [Related]  

  • 7. Managed competition. A guide to the thicket.
    Kotelchuck R
    Health PAC Bull; 1993; 23(1):4-12. PubMed ID: 10126180
    [No Abstract]   [Full Text] [Related]  

  • 8. Managed competition, integrated delivery systems and antitrust.
    Greaney TL
    Cornell Law Rev; 1994 Sep; 79(6):1507-45. PubMed ID: 10141442
    [No Abstract]   [Full Text] [Related]  

  • 9. Managed competition--blessing or curse?
    Halamandaris VJ
    Caring; 1993 Jun; 12(6):32-3. PubMed ID: 10125990
    [No Abstract]   [Full Text] [Related]  

  • 10. Testimony on managed competition. The Jackson Hole approach. Achieving effective cost control in comprehensive health care reform.
    Enthoven A
    Caring; 1993 Jun; 12(6):16-8. PubMed ID: 10125987
    [No Abstract]   [Full Text] [Related]  

  • 11. Testimony on managed competition. The effects of cost control provisions on health expenditures.
    Reischauer RD
    Caring; 1993 Jun; 12(6):18, 20, 23-8. PubMed ID: 10125988
    [No Abstract]   [Full Text] [Related]  

  • 12. Managed competition: reform or retreat? Analysis, critique, alternatives.
    Health PAC Bull; 1993; 23(1):3-47. PubMed ID: 10126176
    [No Abstract]   [Full Text] [Related]  

  • 13. Managed competition and public health. Let's do the right thing.
    McKenzie N
    Health PAC Bull; 1993; 23(1):33-6. PubMed ID: 10126178
    [No Abstract]   [Full Text] [Related]  

  • 14. Washington mulls over managed-care reform options.
    Scott JS
    Comput Healthc; 1993 Apr; 14(4):22-3, 25-6. PubMed ID: 10125049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care reform. Six questions for President Clinton.
    Wiener JM; Illston LH
    Brookings Rev; 1993; 11(2):22-5. PubMed ID: 10124884
    [No Abstract]   [Full Text] [Related]  

  • 17. Washington readies for managed competition.
    Riley T; Mollica RL
    Bus Health; 1993 Aug; 11(9):61-2. PubMed ID: 10127883
    [No Abstract]   [Full Text] [Related]  

  • 18. CalPERS: a model for health care reform?
    Findlay S
    Bus Health; 1993 Jun; 11(7):45, 48, 50 passim. PubMed ID: 10126715
    [No Abstract]   [Full Text] [Related]  

  • 19. Encrypted signals.
    Kosterlitz J
    Natl J (Wash); 1993 May; 25(18):1030-4. PubMed ID: 10125571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of Clinton's health care reform plan on the managed care industry.
    Pavarini PA; Dunlay CT
    Healthspan; 1993 Mar; 10(3):3-8. PubMed ID: 10125345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.